Depression and pain increase fatigue in breast cancer survivors

Understanding fatigue-related factors following breast cancer treatment helps in survival recovery. Credit: SINC. OC.

In Spain, 5-year survival following breast cancer diagnosis is more than 83%. Around 66% suffer fatigue following treatment. A Spanish research establishes the factors associated with tiredness in cancer survivors to improve their quality of life and rehabilitation.

"Cancer-related fatigue is the symptom that most limits quality of life and is most common in patients that survive cancerous processes," explained Manuel Arroyo, researcher from the University of Granada and lead author of a study that links and physical pain episodes with fatigue after treating a breast tumour.

More than 66% of suffer tiredness following recovery, caused directly by the disease, physical deterioration or the treatment received. Therefore, understanding the factors related with fatigue and how they can be alleviated optimises survivors' recovery.

Fifty-nine treated for were followed-up one year after having clinically overcome the disease. The researchers assessed their psychological and physical condition as well as different aspects linked to the typical medical symptoms following a cancerous process (tiredness, pain, limited movement, depression, etc.).

A statistical procedure (resampling) allowed inferences to be made similar to those that would be obtained from larger samples. "This method means that the data were more reliable and eliminated the problem of having a reduced sample size," explained Arroyo. "It is difficult to find volunteers because patients are not often very willing to participate in research after having been through such harsh treatment."

The results show that the patients most affected by tiredness following treatment also suffer episodes of depression and body image deterioration, neck and shoulder pain, and limited , possibly due to the .

Effects of survival

Following , patients present with physical and psychological symptoms that influence their health.

Previous studies have already observed self-esteem- and body image-related disorders following the cancerous process. But for the first time, a team of researchers has associated sensory hypersensitivity, limited movement and certain psychological conditions with fatigue observed following cancer treatment.

"These findings should motivate patient support programmes which improve their psychological condition and offer resources that can reduce pain," pointed out Arroyo, who further stressed that "if fatigue is not treated, patients can suffer it for years, having a serious physical, emotional, social and economic impact."

More information: Cantarero Villanueva, Antarero Villanueva, C- Fernández Lao, C. Fernández de las Peñas, L. Díaz Rodríguez, E. Sánchez Cantalejo, M. Arroyo Morales. "Associations among musculoskeletal impairments, depression, body image and fatigue in breast cancer survivors within the first year after treatment". European Journal of Cancer Care 20 (2011): 632-636, 11th Septembre 2011.

Related Stories

Underestimated Late Effects of Breast Cancer

date Oct 27, 2006

Women who have been successfully treated for breast cancer are still not in good health for many years. In a study on more than 300 affected women, epidemiologists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, ...

Recommended for you

DNA blood test detects lung cancer mutations

date 12 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date 15 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date 15 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.